Ignite Creation Date:
2025-12-24 @ 1:36 PM
Ignite Modification Date:
2026-02-26 @ 4:18 PM
Study NCT ID:
NCT02598895
Status:
COMPLETED
Last Update Posted:
2022-11-17
First Post:
2015-10-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway
Sponsor:
University of Washington
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-13
First Submit QC Date:
None
Study First Post Date:
2015-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-08
Results First Submit QC Date:
None
Results First Post Date:
2022-11-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-24
Last Update Post Date:
2022-11-17
Last Update Post Date Type:
ACTUAL